424 related articles for article (PubMed ID: 24650269)
21. Lipoprotein-associated phospholipase A2 is a risk factor for diabetic kidney disease.
Hu Y; Li TT; Zhou W; Lu TT; Li FF; Ding B; Liu BL; Xie XJ; Ma JH
Diabetes Res Clin Pract; 2019 Apr; 150():194-201. PubMed ID: 30904742
[TBL] [Abstract][Full Text] [Related]
22. Lipoprotein-associated phospholipase A2 and its relationship with markers of subclinical cardiovascular disease: A systematic review.
Younus A; Humayun C; Ahmad R; Ogunmoroti O; Kandimalla Y; Aziz M; Malik R; Saand AR; Valdes C; Badlani R; Younus MA; Ali SS; Chen Y; Nasir K
J Clin Lipidol; 2017; 11(2):328-337. PubMed ID: 28502488
[TBL] [Abstract][Full Text] [Related]
23. Expression of Hypoxia-Inducible Factor-1α (HIF1A) and Lp-PLA2 in Low, Intermediate, and High Cardiovascular Disease Risk Population.
Heriansyah T; Chomsy IN; Kumboyono K; Pratiwi PA; Wihastuti TA
Vasc Health Risk Manag; 2020; 16():507-513. PubMed ID: 33299319
[TBL] [Abstract][Full Text] [Related]
24. Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patients.
Raichlin E; McConnell JP; Bae JH; Kremers WK; Lerman A; Frantz RP
Transplantation; 2008 Apr; 85(7):963-8. PubMed ID: 18408575
[TBL] [Abstract][Full Text] [Related]
25. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans.
Lavi S; McConnell JP; Rihal CS; Prasad A; Mathew V; Lerman LO; Lerman A
Circulation; 2007 May; 115(21):2715-21. PubMed ID: 17502572
[TBL] [Abstract][Full Text] [Related]
26. Energy Intake and Plasma Adiponectin as Potential Determinants of Lipoprotein-Associated Phospholipase A
Ntzouvani A; Giannopoulou E; Fragopoulou E; Nomikos T; Antonopoulou S
Lipids; 2019 Oct; 54(10):629-640. PubMed ID: 31489677
[TBL] [Abstract][Full Text] [Related]
27. Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow.
Ding YD; Pei YQ; Wang R; Yang JX; Zhao YX; Liu XL; Shen H; Ma Q; Zhang S; Ge HL
BMC Cardiovasc Disord; 2020 May; 20(1):248. PubMed ID: 32460702
[TBL] [Abstract][Full Text] [Related]
28. Gender-related and PUFA-related differences in lipoprotein-associated phospholipase A2 levels in patients with type 2 diabetes and atherosclerotic cardiovascular disease.
Hanarz M; Siniarski A; Gołębiowska-Wiatrak R; Nessler J; Malinowski KP; Gajos G
Adv Clin Exp Med; 2024 Jun; 33(6):593-600. PubMed ID: 37747445
[TBL] [Abstract][Full Text] [Related]
29. Lipoprotein-associated phospholipase A2 predicts cardiovascular death in patients on maintenance hemodialysis: a 7-year prospective cohort study.
Lin L; Teng J; Shi Y; Xie Q; Shen B; Xiang F; Cao X; Ding X; Xu X; Zhang Z
Lipids Health Dis; 2024 Jan; 23(1):15. PubMed ID: 38216940
[TBL] [Abstract][Full Text] [Related]
30. Serum lipoprotein-associated phospholipase A2 predicts the formation of carotid artery plaque and its vulnerability in anterior circulation cerebral infarction.
Yang Y; Xue T; Zhu J; Xu J; Hu X; Wang P; Kong T; Yan Y; Yang L; Xue S
Clin Neurol Neurosurg; 2017 Sep; 160():40-45. PubMed ID: 28644968
[TBL] [Abstract][Full Text] [Related]
31. Lipoprotein-associated phospholipase A2 predicted cardiovascular disease in obstructive sleep apnea syndrome.
Xu C; Yu F; Mao S; Shi Y; Li Q; Fang S; Tan Y; Gu W; Ye L
Respir Med; 2020 Mar; 163():105881. PubMed ID: 32056835
[TBL] [Abstract][Full Text] [Related]
32. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
[TBL] [Abstract][Full Text] [Related]
33. Association of lipoprotein-associated phospholipase A2 with coronary calcification among American and Japanese men.
El-Saed A; Sekikawa A; Zaky RW; Kadowaki T; Takamiya T; Okamura T; Edmundowicz D; Kita Y; Kuller LH; Ueshima H
J Epidemiol; 2007 Nov; 17(6):179-85. PubMed ID: 18094516
[TBL] [Abstract][Full Text] [Related]
34. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
[TBL] [Abstract][Full Text] [Related]
35. Lipoprotein phospholipase A2 in patients with isolated coronary artery ectasia.
Korkmaz L; Erkuş E; Kırış A; Ağaç MT; Acar Z; Turan T; Erkan H; Dursun I; Celik S
Clin Res Cardiol; 2011 Jun; 100(6):511-4. PubMed ID: 21207044
[TBL] [Abstract][Full Text] [Related]
36. Lipoprotein-associated phospholipase A2 predicts cardiovascular events in dialyzed patients.
De Mauri A; Vidali M; Chiarinotti D; Bellomo G; Rolla R
J Nephrol; 2019 Apr; 32(2):283-288. PubMed ID: 30168082
[TBL] [Abstract][Full Text] [Related]
37. Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2.
Lourida ES; Georgiadis AN; Papavasiliou EC; Papathanasiou AI; Drosos AA; Tselepis AD
Arthritis Res Ther; 2007; 9(1):R19. PubMed ID: 17326817
[TBL] [Abstract][Full Text] [Related]
38. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
[TBL] [Abstract][Full Text] [Related]
39. Lp-PLA2 evaluates the severity of carotid artery stenosis and predicts the occurrence of cerebrovascular events in high stroke-risk populations.
Zhang F; Guo J; Yang F; Zhou Y
J Clin Lab Anal; 2021 Mar; 35(3):e23691. PubMed ID: 33458873
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of lipoprotein-associated phosholipase A2 and plaque burden/composition in young adults.
Celik O; Ozturk D; Akin F; Satilmis S; Yalcin AA; Erturk M; Ayca B; Akturk F; Birand A; Pusuroglu H; Kaya MG
Coron Artery Dis; 2015 May; 26(3):266-71. PubMed ID: 25647459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
